Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries - PubMed (original) (raw)

Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries

Matthew J Durand et al. Am J Physiol Heart Circ Physiol. 2010 Oct.

Abstract

The goals of this study were to 1) determine the acute effect of ANG-(1-7) on vascular tone in isolated middle cerebral arteries (MCAs) from Sprague-Dawley rats fed a normal salt (NS; 0.4% NaCl) diet, 2) evaluate the ability of chronic intravenous infusion of ANG-(1-7) (4 ng·kg(-1)·min(-1)) for 3 days to restore endothelium-dependent dilation to acetylcholine (ACh) in rats fed a high-salt (HS; 4% NaCl) diet, and 3) determine whether the amelioration of endothelial dysfunction by ANG-(1-7) infusion in rats fed a HS diet is different from the protective effect of low-dose ANG II infusion in salt-fed rats. MCAs from rats fed a NS diet dilated in response to exogenous ANG-(1-7) (10(-10)-10(-5) M). Chronic ANG-(1-7) infusion significantly reduced vascular superoxide levels and restored the nitric oxide-dependent dilation to ACh (10(-10)-10(-5) M) that was lost in MCAs of rats fed a HS diet. Acute vasodilation to ANG-(1-7) and the restoration of ACh-induced dilation by chronic ANG-(1-7) infusion in rats fed a HS diet were blocked by the Mas receptor antagonist [D-ALA(7)]-ANG-(1-7) or the ANG II type 2 receptor antagonist PD-123319 and unaffected by ANG II type 1 receptor blockade with losartan. The restoration of ACh-induced dilation in MCAs of HS-fed rats by chronic intravenous infusion of ANG II (5 ng·kg(-1)·min(-1)) was blocked by losartan and unaffected by d-ALA. These findings demonstrate that circulating ANG-(1-7), working via the Mas receptor, restores endothelium-dependent vasodilation in cerebral resistance arteries of animals fed a HS diet via mechanisms distinct from those activated by low-dose ANG II infusion.

PubMed Disclaimer

Figures

Fig. 1.

Fig. 1.

Response of isolated middle cerebral arteries from rats fed a normal salt diet to ANG-(1-7) (10−10–10−5 M; n = 8) before and after acute addition of the Mas receptor antagonist

d

-ALA (10 μM; n = 6), the AT1 receptor antagonist losartan (10 μM; n = 6), or the AT2 receptor antagonist PD-123319 (1 μM; n = 6) to the tissue bath. *P < 0.05, inhibitor vs. control.

Fig. 2.

Fig. 2.

Response to acetylcholine (10−10–10−5 M) (A) and sodium nitroprusside (10−12–10−4 M) (B) in isolated middle cerebral arteries from rats fed a high-salt diet (n = 7 to 8) vs. rats fed a high-salt diet and receiving a 3-day infusion of ANG-(1-7) (4 ng·kg−1·min−1; n = 7) or a 3-day infusion of isotonic saline (n = 6 to 7). *P < 0.05, high-salt ANG-(1-7) infused vs. high-salt and high salt-saline infused.

Fig. 3.

Fig. 3.

Response to acetylcholine (10−10–10−5 M) (A) and sodium nitroprusside (10−12–10−4 M) (B) in isolated middle cerebral arteries from rats fed a normal salt diet (n = 6) vs. normal salt-fed rats receiving a chronic 3-day infusion of ANG-(1-7) (4 ng·kg−1·min−1; n = 7) or 3-day isotonic saline infusion (n = 5 to 6).

Fig. 4.

Fig. 4.

Response to acetylcholine (10−10–10−5 M) in isolated middle cerebral arteries from rats fed a high-salt diet and receiving a 3-day infusion of ANG-(1-7) (4 ng·kg−1·min−1; n = 7) ± the nitric oxide synthase inhibitor _N_ω-nitro-

l

-arginine methyl ester (

l

-NAME, 100 μM; n = 7) in the perfusate and superfusate. Data from the ANG-(1-7) infused group are replotted from Fig. 2_A_. *P < 0.05,

l

-NAME treated vs. ANG-(1-7) infused.

Fig. 5.

Fig. 5.

Response to acetylcholine (10−10–10−5 M) in isolated middle cerebral arteries from rats fed a high-salt diet and receiving a chronic (3 days) intravenous infusion of ANG-(1-7) (n = 7) or a simultaneous infusion of ANG-(1-7) +

d

-ALA (n = 6) (A), an infusion of ANG-(1-7) (n = 7) or a simultaneous infusion of ANG-(1-7) + losartan (n = 8) (B), or an infusion of ANG-(1-7) (n = 7) or a simultaneous infusion of ANG-(1-7) + PD-123319 (n = 10) (C). Data from the ANG-(1-7) infused control group are replotted from Fig. 2_A_. *P < 0.05, ANG-(1-7) + inhibitor vs. ANG-(1-7) infused.

Fig. 6.

Fig. 6.

Response to acetylcholine (10−10–10−5 M) in isolated middle cerebral arteries from rats fed a high-salt diet receiving an infusion of isotonic saline (n = 6), an infusion of ANG II (5 ng·kg−1·min−1; n = 6), or a simultaneous infusion of ANG II +

d

-ALA (n = 6) or ANG II + losartan (n = 6). *P < 0.05, ANG II infused and ANG II +

d

-ALA coinfused vs. saline infused and ANG II + losartan coinfused.

Fig. 7.

Fig. 7.

A: representative bright-field and fluorescent images of basilar artery cross sections (10 μm) from high salt-fed rats receiving a 3-day infusion of either isotonic saline or ANG-(1-7). The vessels were stained with dihydroethidium (5 μM) to assess vascular superoxide levels. B: vascular superoxide levels quantified as brightness values in dihydroethidium-stained basilar artery cross sections from high salt-fed rats receiving a 3-day infusion of either isotonic saline (n = 6) or ANG-(1-7) (n = 5). Data are expressed as means (brightness values) ± SE. *P < 0.05, ANG-(1-7) infused vs. saline infused.

Fig. 8.

Fig. 8.

A: representative bright-field and fluorescent images of basilar artery cross sections (10 μm) from normal salt-fed rats receiving a 3-day infusion of either isotonic saline or ANG-(1-7). The vessels were stained with dihydroethidium (5 μM) to assess vascular superoxide levels. B: vascular superoxide levels quantified as brightness values in dihydroethidium-stained basilar artery cross sections from normal salt-fed rats receiving a 3-day infusion of either isotonic saline (n = 6) or ANG-(1-7) (n = 6). Data are expressed as means (brightness values) ± SE.

Similar articles

Cited by

References

    1. Benter IF, Yousif MH, Dhaunsi GS, Kaur J, Chappell MC, Diz DI. Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 28: 25–33, 2008 - PubMed
    1. Boegehold MA. Flow-dependent arteriolar dilation in normotensive rats fed low- or high-salt diets. Am J Physiol Heart Circ Physiol 269: H1407–H1414, 1995 - PubMed
    1. Brosnihan KB, Li P, Tallant EA, Ferrario CM. Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res 31: 227–234, 1998 - PubMed
    1. Campbell DJ, Kladis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 23: 439–449, 1994 - PubMed
    1. Canals M, Jenkins L, Kellett E, Milligan G. Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq/G11 by MAS. J Biol Chem 281: 16757–16767, 2006 - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources